Amedica

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Amedica and buy or sell other stocks, ETFs, and their options commission-free!

About AMDA

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. 

CEO
Eric Kenneth Olson
CEOEric Kenneth Olson
Employees
Employees
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1996
Founded1996
Employees
Employees

AMDA Key Statistics

Market cap
10.79M
Market cap10.79M
Price-Earnings ratio
-0.40
Price-Earnings ratio-0.40
Dividend yield
Dividend yield
Average volume
33.30K
Average volume33.30K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.78
52 Week high$6.78
52 Week low
$1.71
52 Week low$1.71

Stock Snapshot

Amedica(AMDA) stock is priced at $0.94, giving the company a market capitalization of 10.79M. It carries a P/E multiple of -0.40.

On 2026-03-17, Amedica(AMDA) stock opened at —, reached a high of —, and a low of —.

The Amedica(AMDA)'s current trading volume is 0, compared to an average daily volume of 33.3K.

During the past year, Amedica(AMDA) stock moved between $1.71 at its lowest and $6.78 at its peak.

During the past year, Amedica(AMDA) stock moved between $1.71 at its lowest and $6.78 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.